StockData
CRONNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31

Cronos Group Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$3.25+0.04 (+1.25%)

Close on Oct 19, 2026

Market cap
$1.22B
P/E (TTM)
16.3
Dividend yield
–

Cronos statistics

Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Medicinal Chemicals & Botanical Products companies for comparison

Valuation

MeasureCronosIndustry median
Market Cap$1.20B$197.05M
Enterprise Value$449.10M$106.56M
PE Ratio16.2520.52
PS Ratio6.693.93
PB Ratio1.122.14
P/TBV Ratio1.202.46
P/FCF Ratio24.0418.25
P/OCF Ratio19.9413.78

Enterprise value

MeasureCronosIndustry median
EV / Sales2.512.69
EV / EBITDA78.9414.86
EV / FCF9.0221.02

Income (trailing twelve months)

MeasureCronosIndustry median
Revenue$179.09M$57.94M
Gross Profit$82.13M$90.47M
Operating Income-$2.43M-$21.44M
Pretax Income$68.47M-$14.45M
Net Income$69.98M-$22.46M
EBITDA$5.69M-$16.91M
EPS (Diluted)$0.20-$0.83

Margins

MeasureCronosIndustry median
Gross Margin45.9%52.3%
Operating Margin-1.36%-44.5%
Pretax Margin38.2%-13.0%
Profit Margin39.1%-39.2%
EBITDA Margin3.18%-31.3%
FCF Margin27.8%-8.85%

Returns

MeasureCronosIndustry median
Return on Equity (ROE)6.51%-53.1%
Return on Assets (ROA)5.94%-41.0%
Return on Invested Capital (ROIC)-0.93%-32.0%
Return on Capital Employed (ROCE)-0.22%-37.8%

Growth

MeasureCronosIndustry median
Revenue Growth (YoY)37.5%6.01%
Net Income Growth (YoY)278.5%-37.7%
EPS Growth (YoY)300.0%-29.2%
Revenue Growth (3Y CAGR)19.1%2.25%
Revenue Growth (5Y CAGR)25.7%6.42%

Balance sheet

MeasureCronosIndustry median
Cash & Short-Term Investments$797.02M$62.42M
Net Cash (Debt)$797.02M$15.68M
Net Cash Per Share$2.16$0.65
Equity (Book Value)$1.07B$48.79M
Book Value Per Share$2.90$1.36
Tangible Book Value$996.48M$23.06M
Working Capital$855.67M$75.77M

Financial position

MeasureCronosIndustry median
Current Ratio16.183.30
Quick Ratio14.792.39

Cash flow (trailing twelve months)

MeasureCronosIndustry median
Operating Cash Flow$60.05M-$12.35M
Capital Expenditures-$10.24M-$1.06M
Free Cash Flow$49.82M-$20.28M
FCF Per Share$0.14-$0.41

Efficiency

MeasureCronosIndustry median
Asset Turnover0.150.38
Inventory Turnover2.042.67
Revenue Per Employee$293.59K$398.96K
Profits Per Employee$114.72K-$732.08K
Employee Count61073

Dividends and yields

MeasureCronosIndustry median
Earnings Yield5.84%-21.2%
FCF Yield4.16%-7.64%
Buyback Yield3.26%-0.58%
Shareholder Yield3.26%0.00%

Shares

MeasureCronosIndustry median
Shares Outstanding368,413,00059,128,900
Shares Change (YoY)-1.94%11.1%
Shares Change (QoQ)-1.47%0.54%
Float342,780,00048,744,500
Shares Held by Insiders6.96%11.8%
Shares Held by Institutions12.9%59.4%

Taxes

MeasureCronosIndustry median
Income Tax-$10.73M$91.50K
Effective Tax Rate-15.7%20.6%

Scores

MeasureCronosIndustry median
Graham Number$3.61$17.36
Graham Upside11.2%-45.5%
Altman Z-Score13.110.10
Piotroski F-Score74
Beneish M-Score-1.87-2.62

Calculated by StockData from Cronos's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.